LEADLESS PACEMAKER NO LEAD NO POCKET NO COMPROMISE
Posted by Natasha Russell on Saturday, October 26, 2013,
MitraClip (Abbott) has received Food and Drug Administration approval for patients with significant symptomatic degenerative mitral regurgitation who are at prohibitive risk for mitral valve surgery.
Posted by Natasha Russell on Saturday, October 26, 2013,
Managing Director, CARDIOVMEDS
Natasha E. Russell |
Kingston, Jamaica |
I have been working in the field of Cardiology and open heart surgery since 1991. I worked first as a perfusionist, then as a cardiovascular technologist. My duties have included working in the cardiac cathetherisation lab, analysising the 24-48 hour ambulatory ECG ( holter), assisting with various diagnostic tests. I have also worked as administrator of the paediatric cardiac surgery program. Key achievements have been presentation at the Caribbean Cardiac Conference on topics such as: Diagnosing Right Ventricular Infarction : The role of the technician Familial Atrial Fibrillation (FAF) Revealed |